Alternative RNA Processing of Topoisomerase IIα in Etoposide-Resistant Human Leukemia K562 Cells: Intron Retention Results in a Novel C-Terminal Truncated 90-kDa Isoform-Reference-Cited by-同舟云学术

Alternative RNA Processing of Topoisomerase IIα in Etoposide-Resistant Human Leukemia K562 Cells: Intron Retention Results in a Novel C-Terminal Truncated 90-kDa Isoform

Published:2016-11-10 Issue:1 Volume:360 Page:152-163
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Kanagasabai Ragu,Serdar Lucas,Karmahapatra Soumendrakrishna,Kientz Corey A.,Ellis Justin,Ritke Mary K.,Elton Terry S.,Yalowich Jack C.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference72 articles.

1. Topoisomerase-mediated chromosomal break repair: an emerging player in many games

2. The Evolutionary Landscape of Alternative Splicing in Vertebrate Species

3. Intron retention facilitates splice variant diversity in calcium-activated big potassium channel populations

4. Cytoplasmic BKCa channel intron-containing mRNAs contribute to the intrinsic excitability of hippocampal neurons

5. A simple method for direct cloning and sequencing cDNA by the use of a single specific oligonucleotide and oligo(dT) in a polymerase chain reaction (PCR)

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circumvention of Topoisomerase IIαIntron 19 Intronic Polyadenylation in Acquired Etoposide-Resistant Human Leukemia K562 Cells;Molecular Pharmacology;2024-05-06

2. Use of CRISPR/Cas9 with Homology-Directed Repair to Gene-Edit Topoisomerase IIβin Human Leukemia K562 Cells: Generation of a Resistance Phenotype;Journal of Pharmacology and Experimental Therapeutics;2024-03-20

3. DNA-PKcs-mediated transcriptional regulation of TOP2B drives chemoresistance in acute myeloid leukemia;Journal of Cell Science;2024-02-01

4. The use of RNA-based treatments in the field of cancer immunotherapy;Molecular Cancer;2023-07-07

5. Maximizing the Efficacy of CRISPR/Cas Homology-Directed Repair Gene Targeting;CRISPR Technology - Recent Advances;2023-01-04